This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gregory, M. A.
Right arrow Articles by Hann, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregory, M. A.
Right arrow Articles by Hann, S. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2000, p. 2423-2435, Vol. 20, No. 7
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells

Mark A. Gregory and Stephen R. Hann*

Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2175

Received 16 June 1999/Returned for modification 22 July 1999/Accepted 11 January 2000

The c-Myc oncoprotein is a transcription factor which is a critical regulator of cellular proliferation. Deregulated expression of c-Myc is associated with many human cancers, including Burkitt's lymphoma. The c-Myc protein is normally degraded very rapidly with a half-life of 20 to 30 min. Here we demonstrate that proteolysis of c-Myc in vivo is mediated by the ubiquitin-proteasome pathway. Inhibition of proteasome activity blocks c-Myc degradation, and c-Myc is a substrate for ubiquitination in vivo. Furthermore, an increase in c-Myc stability occurs in mitotic cells and is associated with inhibited c-Myc ubiquitination. Deletion analysis was used to identify regions of the c-Myc protein which are required for rapid proteolysis. We found that a centrally located PEST sequence, amino acids 226 to 270, is necessary for rapid c-Myc degradation, but not for ubiquitination. Also, N-terminal sequences, located within the first 158 amino acids of c-Myc, are necessary for both efficient c-Myc ubiquitination and subsequent degradation. We found that c-Myc is significantly stabilized (two- to sixfold) in many Burkitt's lymphoma-derived cell lines, suggesting that aberrant c-Myc proteolysis may play a role in the pathogenesis of Burkitt's lymphoma. Finally, mutation of Thr-58, a major phosphorylation site in c-Myc and a mutational hot spot in Burkitt's lymphoma, increases c-Myc stability; however, mutation of c-Myc is not essential for stabilization in Burkitt's lymphoma cells.

* Corresponding author. Mailing address: Department of Cell Biology, MCN C-2310, Vanderbilt University School of Medicine, Nashville, TN 37232-2175. Phone: (615) 343-4344. Fax: (615) 343-5791. E-mail: steve.hann{at}mcmail.vanderbilt.edu.

Molecular and Cellular Biology, April 2000, p. 2423-2435, Vol. 20, No. 7
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Galletti, M., Riccardo, S., Parisi, F., Lora, C., Saqcena, M. K., Rivas, L., Wong, B., Serra, A., Serras, F., Grifoni, D., Pelicci, P., Jiang, J., Bellosta, P. (2009). Identification of Domains Responsible for Ubiquitin-Dependent Degradation of dMyc by Glycogen Synthase Kinase 3{beta} and Casein Kinase 1 Kinases. Mol. Cell. Biol. 29: 3424-3434 [Abstract] [Full Text]  
  • Khanna, A., Bockelman, C., Hemmes, A., Junttila, M. R., Wiksten, J.-P., Lundin, M., Junnila, S., Murphy, D. J., Evan, G. I., Haglund, C., Westermarck, J., Ristimaki, A. (2009). MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer. JNCI J Natl Cancer Inst 101: 793-805 [Abstract] [Full Text]  
  • Wang, X., Naidu, S. R., Sverdrup, F., Androphy, E. J. (2009). Tax1BP1 Interacts with Papillomavirus E2 and Regulates E2-Dependent Transcription and Stability. J. Virol. 83: 2274-2284 [Abstract] [Full Text]  
  • Bonetti, P., Davoli, T., Sironi, C., Amati, B., Pelicci, P. G., Colombo, E. (2008). Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7{gamma}. JCB 182: 19-26 [Abstract] [Full Text]  
  • Brady, G, MacArthur, G J, Farrell, P J (2008). Epstein-Barr virus and Burkitt lymphoma. Postgrad. Med. J. 84: 372-377 [Abstract] [Full Text]  
  • Bajaj, B. G., Murakami, M., Cai, Q., Verma, S. C., Lan, K., Robertson, E. S. (2008). Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein. J. Virol. 82: 4082-4090 [Abstract] [Full Text]  
  • Brady, G, MacArthur, G J, Farrell, P J (2007). Epstein Barr virus and Burkitt lymphoma. J. Clin. Pathol. 60: 1397-1402 [Abstract] [Full Text]  
  • Liu, J., Martin, H. J., Liao, G., Hayward, S. D. (2007). The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc. J. Virol. 81: 10451-10459 [Abstract] [Full Text]  
  • Bartholomeusz, G., Talpaz, M., Bornmann, W., Kong, L.-Y., Donato, N. J. (2007). Degrasyn Activates Proteasomal-Dependent Degradation of c-Myc. Cancer Res. 67: 3912-3918 [Abstract] [Full Text]  
  • Vervoorts, J., Luscher-Firzlaff, J., Luscher, B. (2006). The Ins and Outs of MYC Regulation by Posttranslational Mechanisms. J. Biol. Chem. 281: 34725-34729 [Abstract] [Full Text]  
  • Chesler, L., Schlieve, C., Goldenberg, D. D., Kenney, A., Kim, G., McMillan, A., Matthay, K. K., Rowitch, D., Weiss, W. A. (2006). Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma. Cancer Res. 66: 8139-8146 [Abstract] [Full Text]  
  • Liso, A., Capello, D., Marafioti, T., Tiacci, E., Cerri, M., Distler, V., Paulli, M., Carbone, A., Delsol, G., Campo, E., Pileri, S., Pasqualucci, L., Gaidano, G., Falini, B. (2006). Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 108: 1013-1020 [Abstract] [Full Text]  
  • Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J. Jr, Lee, K. P., Boise, L. H. (2006). Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107: 4907-4916 [Abstract] [Full Text]  
  • Gil-Bernabe, A. M., Romero, F., Limon-Mortes, M. C., Tortolero, M. (2006). Protein Phosphatase 2A Stabilizes Human Securin, Whose Phosphorylated Forms Are Degraded via the SCF Ubiquitin Ligase.. Mol. Cell. Biol. 26: 4017-4027 [Abstract] [Full Text]  
  • Cowling, V. H., Chandriani, S., Whitfield, M. L., Cole, M. D. (2006). A Conserved Myc Protein Domain, MBIV, Regulates DNA Binding, Apoptosis, Transformation, and G2 Arrest.. Mol. Cell. Biol. 26: 4226-4239 [Abstract] [Full Text]  
  • Rahaus, M., Desloges, N., Wolff, M. H. (2006). Varicella-zoster virus influences the activities of components and targets of the ERK signalling pathway.. J. Gen. Virol. 87: 749-758 [Abstract] [Full Text]  
  • Arnold, H. K., Sears, R. C. (2006). Protein Phosphatase 2A Regulatory Subunit B56{alpha} Associates with c-Myc and Negatively Regulates c-Myc Accumulation.. Mol. Cell. Biol. 26: 2832-2844 [Abstract] [Full Text]  
  • Sundberg, T. B., Ney, G. M., Subramanian, C., Opipari, A. W. Jr., Glick, G. D. (2006). The Immunomodulatory Benzodiazepine Bz-423 Inhibits B-Cell Proliferation by Targeting c-Myc Protein for Rapid and Specific Degradation. Cancer Res. 66: 1775-1782 [Abstract] [Full Text]  
  • Yeh, E. S., Lew, B. O., Means, A. R. (2006). The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability. J. Biol. Chem. 281: 241-251 [Abstract] [Full Text]  
  • Rottmann, S., Wang, Y., Nasoff, M., Deveraux, Q. L., Quon, K. C. (2005). From the Cover: A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3{beta}/FBW7 loss of function. Proc. Natl. Acad. Sci. USA 102: 15195-15200 [Abstract] [Full Text]  
  • Pervan, M., Iwamoto, K. S., McBride, W. H. (2005). Proteasome Structures Affected by Ionizing Radiation. Mol Cancer Res 3: 381-390 [Abstract] [Full Text]  
  • Kotani, A., Okazaki, I.-m., Muramatsu, M., Kinoshita, K., Begum, N. A., Nakajima, T., Saito, H., Honjo, T. (2005). A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc. Natl. Acad. Sci. USA 102: 4506-4511 [Abstract] [Full Text]  
  • Llano, M., Delgado, S., Vanegas, M., Poeschla, E. M. (2004). Lens Epithelium-derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase. J. Biol. Chem. 279: 55570-55577 [Abstract] [Full Text]  
  • Blum, K. A., Lozanski, G., Byrd, J. C. (2004). Adult Burkitt leukemia and lymphoma. Blood 104: 3009-3020 [Abstract] [Full Text]  
  • Pasqualucci, L., Guglielmino, R., Houldsworth, J., Mohr, J., Aoufouchi, S., Polakiewicz, R., Chaganti, R. S. K., Dalla-Favera, R. (2004). Expression of the AID protein in normal and neoplastic B cells. Blood 104: 3318-3325 [Abstract] [Full Text]  
  • Welcker, M., Orian, A., Jin, J., Grim, J. E., Harper, J. W., Eisenman, R. N., Clurman, B. E. (2004). From The Cover: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 101: 9085-9090 [Abstract] [Full Text]  
  • Logan, I. R., Sapountzi, V., Gaughan, L., Neal, D. E., Robson, C. N. (2004). Control of Human PIRH2 Protein Stability: INVOLVEMENT OF TIP60 AND THE PROTEASOME. J. Biol. Chem. 279: 11696-11704 [Abstract] [Full Text]  
  • Huang, Z., Traugh, J. A., Bishop, J. M. (2004). Negative Control of the Myc Protein by the Stress-Responsive Kinase Pak2. Mol. Cell. Biol. 24: 1582-1594 [Abstract] [Full Text]  
  • Alarcon-Vargas, D., Ronai, Z.'e. (2004). c-Jun-NH2 Kinase (JNK) Contributes to the Regulation of c-Myc Protein Stability. J. Biol. Chem. 279: 5008-5016 [Abstract] [Full Text]  
  • Gregory, M. A., Qi, Y., Hann, S. R. (2003). Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization. J. Biol. Chem. 278: 51606-51612 [Abstract] [Full Text]  
  • Gaidano, G., Pasqualucci, L., Capello, D., Berra, E., Deambrogi, C., Rossi, D., Maria Larocca, L., Gloghini, A., Carbone, A., Dalla-Favera, R. (2003). Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 102: 1833-1841 [Abstract] [Full Text]  
  • Arabi, A., Rustum, C., Hallberg, E., Wright, A. P. H. (2003). Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J. Cell Sci. 116: 1707-1717 [Abstract] [Full Text]  
  • Piva, R., Liu, J., Chiarle, R., Podda, A., Pagano, M., Inghirami, G. (2002). In Vivo Interference with Skp1 Function Leads to Genetic Instability and Neoplastic Transformation. Mol. Cell. Biol. 22: 8375-8387 [Abstract] [Full Text]  
  • Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., Munshi, N. C., Richardson, P. G., Hideshima, T., Anderson, K. C. (2002). Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA 99: 14374-14379 [Abstract] [Full Text]  
  • Flinn, E. M., Wallberg, A. E., Hermann, S., Grant, P. A., Workman, J. L., Wright, A. P. H. (2002). Recruitment of Gcn5-containing Complexes during c-Myc-dependent Gene Activation. STRUCTURE AND FUNCTION ASPECTS. J. Biol. Chem. 277: 23399-23406 [Abstract] [Full Text]  
  • Tang, T., Arbiser, J. L., Brandt, S. J. (2002). Phosphorylation by Mitogen-activated Protein Kinase Mediates the Hypoxia-induced Turnover of the TAL1/SCL Transcription Factor in Endothelial Cells. J. Biol. Chem. 277: 18365-18372 [Abstract] [Full Text]  
  • Kamemura, K., Hayes, B. K., Comer, F. I., Hart, G. W. (2002). Dynamic Interplay between O-Glycosylation and O-Phosphorylation of Nucleocytoplasmic Proteins. ALTERNATIVE GLYCOSYLATION/PHOSPHORYLATION OF THR-58, A KNOWN MUTATIONAL HOT SPOT OF c-Myc IN LYMPHOMAS, IS REGULATED BY MITOGENS. J. Biol. Chem. 277: 19229-19235 [Abstract] [Full Text]  
  • Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C., Maslyar, D. J., Goldberg, J., Boger, D. L., Vogt, P. K. (2002). Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 99: 3830-3835 [Abstract] [Full Text]  
  • Baudino, T. A., Cleveland, J. L. (2001). The Max Network Gone Mad. Mol. Cell. Biol. 21: 691-702 [Full Text]  
  • Hecht, J. L., Aster, J. C. (2000). Molecular Biology of Burkitt's Lymphoma. JCO 18: 3707-3721 [Abstract] [Full Text]  
  • Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., Nevins, J. R. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14: 2501-2514 [Abstract] [Full Text]  
  • Niklinski, J., Claassen, G., Meyers, C., Gregory, M. A., Allegra, C. J., Kaye, F. J., Hann, S. R., Zajac-Kaye, M. (2000). Disruption of Myc-Tubulin Interaction by Hyperphosphorylation of c-Myc during Mitosis or by Constitutive Hyperphosphorylation of Mutant c-Myc in Burkitt's Lymphoma. Mol. Cell. Biol. 20: 5276-5284 [Abstract] [Full Text]  
  • Ogretmen, B., Kraveka, J. M., Schady, D., Usta, J., Hannun, Y. A., Obeid, L. M. (2001). Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition in the A549 Human Lung Adenocarcinoma Cell Line. J. Biol. Chem. 276: 32506-32514 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»